No profile data available.
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) is a healthcare company in the additional cancer treatment drugs industry, based in Gaithersburg, United States, with about 2 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$11.72 million. Its market capitalization was $25.40 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Shuttle Pharmaceuticals reported $0 in revenue for fiscal year 2025.
$25.40 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include Context Therapeutics Inc. (CNTX), Intensity Therapeutics, Inc. (INTS), Immutep Limited (IMMP), Akari Therapeutics, Plc (AKTX).